An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors-Reference-Cited by-同舟云学术

An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors

Published:2004-12-15 Issue:24 Volume:64 Page:9139-9143
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Amador Maria L.,Oppenheimer Darin,Perea Sofia,Maitra Anirban,Cusati George,Iacobuzio-Donahue Christi,Baker Sharyn D.,Ashfaq Raheela,Takimoto Chris,Forastiere Arlene,Hidalgo Manuel

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Side effects of tyrosine kinase inhibitors therapy in patients with non‑small cell lung cancer and associations with EGFR polymorphisms: A systematic review and meta‑analysis;Oncology Letters;2022-12-23

2. Analyses of P16INK4a gene promoter methylation relative to molecular, demographic and clinical parameters characteristics in non-small cell lung cancer patients: A pilot study;Molecular Biology Reports;2022-11-15

3. Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers;Expert Review of Clinical Pharmacology;2022-06-03

4. Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer;Drug Resistance Updates;2022-05

5. Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies;Frontiers in Oncology;2022-02-10